TRDA
Entrada Therapeutics, Inc. · Healthcare
Chief Medical Officer Nerissa Kreher sold $277K of Entrada Therapeutics, Inc.
Sold$276,549
$21.27Price
13,000Shares
−39%Stake
What TRDA did after the filing
- The stock from Thu, Oct 27 close, $21.22
- −10.1%
- S&P 500, same days
- +3.5%
Measured over 30 trading days, to the Dec 9 close.
Traded Tue, Oct 25. Filed Thu, Oct 27, 2:49 PM ET, during the session. Returns use the Oct 27 close and the Dec 9 close. Not investment advice.